Nanoscale characterization of drug-induced microtubule filament dysfunction using super-resolution microscopy
Open Access
- 11 December 2021
- journal article
- research article
- Published by Springer Nature in BMC Biology
- Vol. 19 (1) , 1-16
Abstract
Background: The integrity of microtubule filament networks is essential for the roles in diverse cellular functions, and disruption of its structure or dynamics has been explored as a therapeutic approach to tackle diseases such as cancer. Microtubule-interacting drugs, sometimes referred to as antimitotics, are used in cancer therapy to target and disrupt microtubules. However, due to associated side effects on healthy cells, there is a need to develop safer drug regimens that still retain clinical efficacy. Currently, many questions remain open regarding the extent of effects on cellular physiology of microtubule-interacting drugs at clinically relevant and low doses. Here, we use super-resolution microscopies (single-molecule localization and optical fluctuation based) to reveal the initial microtubule dysfunctions caused by nanomolar concentrations of colcemid. Results: We identify previously undetected microtubule (MT) damage caused by clinically relevant doses of colcemid. Short exposure to 30–80 nM colcemid results in aberrant microtubule curvature, with a trend of increased curvature associated to increased doses, and curvatures greater than 2 rad/μm, a value associated with MT breakage. Microtubule fragmentation was detected upon treatment with ≥ 100 nM colcemid. Remarkably, lower doses (< 20 nM after 5 h) led to subtle but significant microtubule architecture remodelling characterized by increased curvature and suppression of microtubule dynamics. Conclusions: Our results support the emerging hypothesis that microtubule-interacting drugs induce non-mitotic effects in cells, and establish a multi-modal imaging assay for detecting and measuring nanoscale microtubule dysfunction. The sub-diffraction visualization of these less severe precursor perturbations compared to the established antimitotic effects of microtubule-interacting drugs offers potential for improved understanding and design of anticancer agents.Keywords
Funding Information
- Australian Research Council (DP170104477, DE200100584)
This publication has 68 references indexed in Scilit:
- Resolution Doubling in 3D-STORM Imaging through Improved BuffersPLOS ONE, 2013
- Cytoskeletal Alterations that Confer Resistance to Anti-tubulin ChemotherapeuticsAnti-Cancer Agents in Medicinal Chemistry, 2013
- Visualization and Analysis of Microtubule Dynamics Using Dual Color-Coded Display of Plus-End LabelsPLOS ONE, 2012
- Modulation of host microtubule dynamics by pathogenic bacteriaBioMolecular Concepts, 2012
- Widely accessible method for superresolution fluorescence imaging of living systemsProceedings of the National Academy of Sciences, 2012
- The proliferation rate paradox in antimitotic chemotherapyMolecular Biology of the Cell, 2012
- Computer Control of Microscopes Using µManagerCurrent Protocols in Molecular Biology, 2010
- Fast, background-free, 3D super-resolution optical fluctuation imaging (SOFI)Proceedings of the National Academy of Sciences, 2009
- Comparison of the neurotoxic effects of colchicine, the vinca alkaloids, and other microtubule poisonsBrain Research, 1989
- Colcemid and colchicine binding to tubulinFEBS Letters, 1979